ECP 2023 Final Programme

E-Posters 114 E-PS-02 009 Vein invasion in breast cancer – a single centre experience Adelina Baltan, United Kingdom S. Costache, A. Gont, A. Chefani, C. D’Arrigo 010 Simultaneous presentation of a giant malignant phyllodes tumour of the breast and high-grade renal cell carcinoma – a rare presentation: a case report Yekaterina Belogrivtseva, USA A. Israh, A. Arriola, M. Mollaee 011 Interobserver agreement between pathologists assessing tumour-infiltrating lymphocytes in breast cancer by applying International TILs Working Group recommendations Emene Benammou, France D. Bacha, I. Mallek, S. Gharbi, M. Hajri, H. Mestiri, A. Lahmar, S. Ben Slama 012 Nonnecrotising granulomatous lymphadeni- tis in the context of autoimmune pseudosar- coidotic reaction Soledad Blasco Muñoz, Spain A. Sánchez Espinosa, A. Ortiz González, E. Guillén Saorín, D. Pérez Parra, C. Capozzi, J. Acosta Ortega, M. Sánchez de las Matas Garre 013 Artificial intelligence-based breast cancer detection facilitates automated prognosis marker assessment using multiplex fluorescence immunohistochemistry Niclas Blessin, Germany T. Mandelkow, E. Bady, M. Lennartz, A. Lebeau, S. Steurer, E. Burandt, T. Clauditz, G. Sauter, M. Graefen, S. Minner, C. Bernreuther 014 Androgen receptors in metastatic triple negative breast cancer João Boavida, Portugal T. Barroso, V. Patel, L. Gonçalves, R. Lopes Brás, M. Esperança Martins, M. Pinho, R. Moiteiro da Cruz, R. Teixeira de Sousa, L. Correia, L. Costa 015 Lymph node involvement in pure ductal carcinoma in situ is rare (DCIS): a study of 575 breast resections with pure DCIS and quantification of sampling Michael Bonert, Canada F. Mrair, P. Williams 016 Primary melanoma of the breast parenchy- ma versus cutaneous mammary melanoma. How to diagnose to improve outcomes – case series Luana-Andreea Bosoteanu, Romania M. Aschie, M. Boșoteanu 017 Invasive papillary carcinoma of the breast. A report of four cases Andrea Canino, Italy A. Ravarino, C. Gerosa, R. Murru, J. Caschili, P. Baldussu, D. Fanni 018 The prognostic and predictive values of androgen receptor expression in breast cancer patients who undergone neoadju- vant chemotherapy Mennan Yigitcan Çelik, Turkey A. Umit, H. Pestereli, A. Tatlı 019 Axillary nodal involvement of post-radiation angiosarcoma of the breast: case report and discussion Amalia-Georgiana Cernat-Stefan, Romania D. Raduta, T. Jaswal, A. Roșulescu, T. Georgescu 020 Diagnostic shift in triple negative breast cancer originating from detailed subtyping and definition of receptor status – a retrospective analysis Lucine Christe, Switzerland E. Werner Rönnerman, A. Kovács, B. Linderholm, A. Valachis, T. Rau 021 Outline of the implementation of a national consensus regarding the translation from guidelines to clinical practice evaluation of the Breast Cancer Biomarker HER2 Nuno Coimbra, Portugal F. Schmitt, J. Magalhães, M. Brito, P. Borralho, S. André, R. Celestino, F. Duarte-Ramos